BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SFL's Managing Director Invited to Speak at MEDTEC Europe Event in Stuttgart, Germany


2/8/2013 11:59:25 AM

PRLog (Press Release) – Feb. 8, 2013 – Attracting 14,000 attendees annually and featuring key experts from industry, MEDTEC Europe has developed into a leading event for the medical technology sector.

During the session on Wednesday 27 February, Shayesteh will be giving a presentation entitled “Optimum classification, conformity assessment and regulatory route for drug/device combinations”. In her talk, she will be giving clear guidance on the different types of combination products, the regulatory route for each classification and requirements to be fulfilled. Furthermore, she will outline proposed changes in the Medical Device Regulation impacting manufacturers of combination products.

“It is important that medtech companies monitor changes in requirements very closely and implement compliance measures timely” commented Shayesteh.

Shayesteh is the Managing Director and founder of SFL. She has comprehensive experience in formulating global regulatory strategies and provides support for the development of drugs, orphan drugs, drug & device combination products, borderline products, medical devices, in vitro diagnostics and advanced therapy medicinal products.

Shayesteh is Chair of the Combination Products Topic Group at EuropaBio. She has been member of the Program Committee of DIA EuroMeeting for 2011, 2012 and 2013 leading the Theme Drugs, Devices, In Vitro Diagnostics and their Combinations and will present on the revised Directives for medical devices and in vitro diagnostics at the upcoming DIA EuroMeeting in Amsterdam

Shayesteh has recently published a number of articles about medical device regulation and related regulatory areas, which are available on the SFL website.

Recently published SFL articles about medical device regulation:

Device Advice

http://www.sfl-services.com/files/news/40_SFL_EPC.pdf

Changes to guidance in the EU and US may simplify the challenging process of product classification for medical device combination products.

Is this the year of more clarity in the EU for products on the pharmaceutical/medical device borderline?

http://www.sfl-services.com/files/news/37_PP2301_Borderli…

Developments in the EU for products on the pharmaceutical / medical device borderline

Source Article from http://www.prlog.org/12076045-sfls-managing-director-invited-to-speak-at-medtec-europe-event-in-stuttgart-germany.html



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES